Approval in severe-to-profound and profound OTOF-related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of participants achieved or surpassed a hearing level meeting the ...
US FDA approves Regeneron’s gene therapy, Otarmeni for genetic hearing loss: Tarrytown, New York Regeneron Pharmaceuticals, Inc., a leadi ...
Approval in severe-to-profound and profound OTOF-related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of participants achieved or surpassed a hearing level meeting the ...
A large, two-year study led by researchers at Johns Hopkins Medicine and consisting of more than 1,400 adults living with ...
A new noninvasive neurostimulation technique capable of reaching deep regions of the brain has been used to elucidate the ...
A new retrospective study published in OTO Open, the open-access journal of the American Academy of Otolaryngology–Head and ...
The National Board of Examinations in Medical Sciences (NBEMS) has issued a notification announcing revisions to its ...
Receiving a diagnosis of Paget disease of the breast can be overwhelming, but understanding the condition is the first step ...
Knee pain often results from injuries to muscles, tendons, or ligaments. Deep vein thrombosis is a severe condition that can cause pain behind your knee. Most minor knee injuries can heal on their own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results